US Patent 7825098 Methods and compositions for modulating Necdin function

Patent 7825098 was granted and assigned to Joslin Diabetes Center (company) on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Joslin Diabetes Center (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7825098

Date of Patent

November 2, 2010

Patent Application Number

11397514

Date Filed

April 4, 2006

Patent Primary Examiner

‌

Sean McGarry

Patent abstract

Described herein are methods for identifying and using inhibitors of Necdin function to promote brown adipose tissue (BAT) differentiation, thereby treating obesity.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7825098 Methods and compositions for modulating Necdin function

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API